Eidos Therapeutics, Inc. Current Ratio 2018-2020 | EIDX
Eidos Therapeutics, Inc. current ratio from 2018 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2020-09-30 |
$0.15B |
$0.01B |
11.11 |
2020-06-30 |
$0.18B |
$0.02B |
11.62 |
2020-03-31 |
$0.20B |
$0.01B |
16.97 |
2019-12-31 |
$0.20B |
$0.01B |
18.78 |
2019-09-30 |
$0.17B |
$0.01B |
17.00 |
2019-06-30 |
$0.14B |
$0.01B |
20.89 |
2019-03-31 |
$0.15B |
$0.01B |
19.04 |
2018-12-31 |
$0.16B |
$0.01B |
33.20 |
2018-09-30 |
$0.17B |
$0.01B |
28.07 |
2018-06-30 |
$0.18B |
$0.01B |
33.79 |
2018-03-31 |
$0.03B |
$0.01B |
5.48 |
2017-12-31 |
$0.01B |
$0.00B |
2.70 |
2017-09-30 |
$0.00B |
|
0.00 |
2017-06-30 |
$0.00B |
|
0.00 |
2017-03-31 |
$0.00B |
|
0.00 |